A pharmaceutical company has announced that 200 jobs will be created at its site in Limerick.
Regeneron said it was investing more than €300 million at its industrial operations and product supply plant in the city.
The company acquired Dell’s old facility in Limerick two years ago for its first production facility outside of America, bringing 300 new jobs to the area.
“I’m delighted to welcome this exciting additional $350 million investment by Regeneron with 200 additional jobs for Limerick on the same day that the government is publishing its Mid-West Action Plan for Jobs,” Enda Kenny said at the Limerick site.
“We are intent on keeping this recovery going by keeping Ireland competitive and by attracting more investment and jobs into the regions. Regeneron’s decision to expand so significantly is testament to the talent pool and attractive business environment available to companies in Ireland.”
Advertisement
Dan Van Plew, the company’s senior vice-president, praised Limerick for helping the company to expand its operations further at Raheen Business Park.
“The entire community has gone out of its way to welcome us and help us create the momentum we need to build this site,” he said.
“Our people — your countrymen — have done something remarkable.
“In less than two years we have brought a dormant building back to life, and are well on our way to building a complex, high-quality facility in industry-leading time.
“Our hundreds of current employees, contractors and trades people are top notch.”
Advertisement
Mr Van Plew said the decision to create another 200 full-time roles “was an easy one” to make because of their experience in Limerick over the last two years. The new recruits will be in their positions by the end of 2017, the company said.
“We are growing, and we need talented people to join us in creating something truly special here in Limerick,” he said.
Regeneron has been ranked the number one employer in the biopharma industry by Science magazine, while Forbes named it one of the world’s most innovative companies.